Provided by Tiger Trade Technology Pte. Ltd.

C4 Therapeutics, Inc.

3.33
+0.20006.39%
Post-market: 3.31-0.0200-0.60%19:49 EDT
Volume:2.61M
Turnover:8.65M
Market Cap:409.67M
PE:-3.67
High:3.37
Open:3.16
Low:3.13
Close:3.13
52wk High:5.17
52wk Low:1.69
Shares:123.03M
Float Shares:94.52M
Volume Ratio:0.94
T/O Rate:2.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9085
EPS(LYR):-1.2666
ROE:-48.14%
ROA:-19.25%
PB:1.66
PE(LYR):-2.63

Loading ...

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 13

C4 Therapeutics reports Q1 EPS (20c), consensus (26c)

TIPRANKS
·
May 12

C4 Therapeutics publishes corporate presentation on targeted protein degradation pipeline, cemsidomide focus

Reuters
·
May 12

C4 Therapeutics Q1 EPS $(0.20) Beats $(0.27) Estimate, Sales $6.152M Beat $3.333M Estimate

Benzinga Earnings
·
May 12

C4 Therapeutics Q1 revenue beats estimates on Biogen milestone payment

Reuters
·
May 12

C4 Therapeutics Q1 FY26 net loss narrows to $25.1 million; revenue drops to $6.2 million

Reuters
·
May 12

BRIEF-C4 Therapeutics Q1 EPS USD -0.2 Vs. IBES Estimate USD -0.37

Reuters
·
May 12

C4 Therapeutics Q1 Revenue USD 6.2 Million VS. Ibes Estimate USD 3.33 Million

THOMSON REUTERS
·
May 12

C4 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights

GlobeNewswire
·
May 12

C4 Therapeutics, Inc expected to post a loss of 37 cents a share - Earnings Preview

Reuters
·
May 01

C4 Therapeutics announces annual shareholder meeting webcast

Reuters
·
Apr 29

Jefferies Remains a Buy on C4 Therapeutics (CCCC)

TIPRANKS
·
Apr 10

C4 Therapeutics adopts Massachusetts, Delaware federal courts as exclusive forums for securities suits

Reuters
·
Apr 10

BUZZ-U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman

Reuters
·
Apr 10

C4 Therapeutics and Roche Expand Partnership with New $1 Billion-Plus Cancer Drug Deal

Deep News
·
Apr 09

C4 Therapeutics Expands Roche Collaboration with New DAC Deal

TIPRANKS
·
Apr 09

C4 Therapeutics publishes corporate presentation outlining cemsidomide, CFT8919 pipeline strategy

Reuters
·
Apr 09

C4 Therapeutics expands Roche DAC collaboration with $20 million upfront payment

Reuters
·
Apr 09

C4 Therapeutics, Inc - C4t Eligible for Tiered Royalties on Future Sales

THOMSON REUTERS
·
Apr 09

C4 Therapeutics, Inc - Agreement Covers Two Oncology Targets With Option for Third Target

THOMSON REUTERS
·
Apr 09